Skip to main content
. 2016 May 24;58:36. doi: 10.1590/S1678-9946201658036

Table 1. - Frequency of isolated multiresistant bacteria in clinical samples from patients with and without cirrhosis.

Bacteria With cirrhosis Without cirrhosis
Total n MR n (%) Total n MR n (%)
Gram-positive †
S. aureus 61 29 (16.7) 469 211 (11.8)
Enterococcus sp. 43 1 (0.6) 169 5 (0.4)
S. viridans 18 1 (0.6) 50 1 (<0.1)
Other Gram-positive bacteria 31 0 165 0
E. faecium 10 7 (4.0) 56 46 (2.6)
E. faecalis 8 0 59 3 (0.2)
Gram-negative
Enterobacteria
E. coli 153 70 (40.2) 992 553 (31.0)
K. pneumoniae 53 28 (16.1) 434 201 (11.3)
Enterobacter sp. 22 9 (5.2) 266 119 (6.7)
Other enterobacteria 9 0 99 22 (1.2)
Proteus sp. 8 3 (1.7) 143 26 (1.4)
Serratia sp. 4 1 (0.6) 128 18 (1.0)
K. oxytoca 0 0 52 21 (1.2)
Nonfermenting Gram-negative Bacilli
P. aeruginosa 12 7 (4.0) 482 219 (12.3)
Acinetobacter sp. 12 10 (5.7) 253 238 (13.3)
Other Nonfermenting Gram-negative Bacilli 11 1 (0.6) 115 52 (2.9)
S. maltophilia 4 4 (2.3) 44 44 (2.5)
A. xylosoxidans 3 3 (1.7) 4 4 (0.2)
Other Gram-negative Bacteria 2 0 61 0
Total of evaluated bacteria 464 174 (100) 4,041 1,783 (100)

Data are presented as the number of samples obtained by direct counting (percentage). MR: multiresistant. † Coagulase-negative Staphylococcus sp. isolates were excluded. by the total number of isolates. ESBL: extended spectrum beta-lactamases.